Timo Minssen
Professor
JUR Center for Advanced Studies in Bioscience Innovation Law
Karen Blixens Plads 16
2300 København S
- Published
Governing, Protecting, and Regulating the Future of Genome Editing: The Significance of ELSPI Perspectives
Slokenberga, S., Minssen, Timo & Nordberg, A., 2022, In: European Journal of Health Law. 29, 3-5, p. 327-340 14 p.Research output: Contribution to journal › Review › Research › peer-review
- Published
Governing, Protecting, and Regulating the Future of Genome Editing (Book): The Significance of ELSPI Perspectives
Slokenberga, S., Minssen, Timo & Nordberg, A., 2023, Leiden: Brill. 320 p.Research output: Book/Report › Book › Research › peer-review
- Published
Happy New Year: From “Weltschmerz” to Pharmaceutical Innovation
Minssen, Timo, 31 Dec 2015Research output: Other contribution › Net publication - Internet publication › Research
- Published
Homomorphic Encryption: The ‘Holy Grail’ for Big Data Analytics & Legal Compliance in the Pharmaceutical and Healthcare Sector?
Corrales Compagnucci, Marcelo, Meszaros, J., Minssen, Timo, Arasilango , A., Ous , T. & Rajarajan, M., 23 Dec 2019, In: European Pharmaceutical Law Review. 3 , 4, p. 144-155 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
How NFTs could transform health information exchange
Kostick-Quenet, K., Mandl, K. D., Minssen, Timo, Cohen, G., Gasser, U., Kohane, I. & McGuire, A. L., 2022, In: Science. 375, 6580, p. 500-502 3 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
How does emerging patent case law in the US and Europe affect precision medicine? How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI?
Aboy, M., Cohen, G., Liddell, K., Liddicoat, J., Crespo, C., Gerke, S. & Minssen, Timo, 2 Oct 2019, In: Nature Biotechnology. 37, 10, p. 1118–1125 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
How much is too much?- Defining the Metes and Bounds of Excessive Pricing in the Pharmaceutical Sector
Kianzad, Behrang & Minssen, Timo, 2018, In: European Pharmaceutical Law Review. 2, 3, p. 133-148 16 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
IPRs in biobanking- risks and opportunities for translational research
Minssen, Timo, Verlinden, M. & Huys, I., Jun 2015, In: Intellectual Property Quarterly. 2015, 2, p. 106-129 24 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
In The U.S. Supreme Court SEQUENOM v. ARIOSA DIAGNOSTICS- On Petition For A Writ Of Certiorari To The U.S. Court Of Appeals For The Federal Circuit, available at: http://www.scotusblog.com/wp-content/uploads/2016/04/32880-pdf-Dhuey.pdf: BRIEF OF TIMO MINSSEN & ROBERT M. SCHWARTZ WITH 10 EUROPEAN & AUSTRALIAN LAW PROFESSORS AS AMICI CURIAE
Minssen, Timo & Schwartz, R. M., 20 Apr 2016, 39 p.Research output: Other contribution › Research
- Published
Incentivizing the Sharing of Healthcare Data in the AI Era
Panagopoulos, A., Minssen, Timo, Sideri, K., Yu, H. & Corrales Compagnucci, Marcelo, 2022, In: Computer Law & Security Review. 45, 10 p., 105670.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 16150437
Most downloads
-
4329
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 1: – Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2190
downloads
The Evolution of the CJEU’s Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2078
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 2: Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published